Skip to main content

Day: April 14, 2025

NAYA Biosciences Announces Strategic Decision to Separate Fertility and Oncology Businesses into Distinct Operations – Company Renamed “INVO Fertility, Inc.”

Public company to operate under new name and concentrate on building, acquiring and operating fertility clinics and the distribution of FDA-cleared INVOcell device Private company to operate as NAYA Therapeutics and focus on clinical development of bifunctional antibodies SARASOTA, Fla., April 14, 2025 (GLOBE NEWSWIRE) — INVO Fertility, Inc., formerly known as NAYA Biosciences, Inc. (the “Company”) (Nasdaq: NAYA), a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, acquisition, and operation of fertility clinics, today announced its decision to separate its fertility and oncology operations. This strategic decision to separate its two principal focus areas is expected to enable both businesses to maximize shareholder value. In connection with the planned separation,...

Continue reading

MediciNova To Participate in D. Boral’s Capital Global Conference on May 14, 2025

LA JOLLA, Calif., April 14, 2025 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announces that their CEO, Yuichi Iwaki, MD, Ph.D., and CBO, David H. Crean, Ph.D., will be participating in investor meetings at D. Boral Capital’s, Inaugural DBC Conference on May 14, 2025 at the Plaza Hotel, New York City. The conference will bring together public and private executives with institutional investors, high-net worth individuals, and corporate clients from various sectors including Healthcare & Life Sciences. Drs. Iwaki and Crean will be discussing MediciNova’s leading programs in neurologic and metabologic disorders. For more information about participation in the DBC Conference, visit https://dboralcapital.com/conference. About...

Continue reading

Vornado’s Retail JV Completes $450 Million Financing of 1535 Broadway

NEW YORK, April 14, 2025 (GLOBE NEWSWIRE) — Vornado Realty Trust (NYSE:VNO) announced today that its 52% owned street retail joint venture has completed a $450 million financing of 1535 Broadway, a premier Times Square retail destination with full blockfront 4K LED signage. The interest only, non–recourse loan carries a fixed rate of 6.90% and matures in May 2030. After transaction costs and reserves, $407 million of the net proceeds from the financing were used to partially redeem Vornado’s Retail JV preferred equity. Vornado Realty Trust is a fully-integrated equity real estate investment trust. CONTACT Thomas J. Sanelli(212) 894-7000 Certain statements contained herein may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not guarantees...

Continue reading

Mullen Group Ltd. To Acquire Leading Customs Brokerage Company

OKOTOKS, Alberta, April 14, 2025 (GLOBE NEWSWIRE) — (TSX: MTL) Mullen Group Ltd. (“Mullen Group“, “We“, “Our” and/or the “Corporation“) is pleased to announce that it has entered into a definitive share purchase agreement to acquire the shares of Cole Group Inc., Cole International Inc., Abco International Freight Inc. and all related entities (collectively the “Cole Group“), subject to receiving regulatory approvals. The parties have filed the necessary regulatory submissions and expect the transaction to close in the second quarter. The Cole Group is an industry leading privately owned, full spectrum logistics services company specializing in customs brokerage, freight forwarding and trade consulting, operating throughout Canada and the United States (“U.S.“)....

Continue reading

Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial Results

–  Appointed John H. Johnson as Executive Chairman; Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer; and Reena Thomas Colacot as Vice President and Head of Quality NEW YORK, April 14, 2025 (GLOBE NEWSWIRE) — Applied Therapeutics, Inc. (Nasdaq: APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today reported financial results for the fourth quarter and full year ended December 31, 2024. “We remain focused on preparing for potential regulatory interactions regarding govorestat in both Classic Galactosemia and Sorbitol Dehydrogenase (“SORD”) Deficiency,” said Les Funtleyder, Interim CEO and CFO of Applied Therapeutics. “As we continue to optimize our strategy for our late-stage...

Continue reading

Applied Materials Announces a Strategic Investment in BE Semiconductor Industries

Purchased 9 percent of outstanding shares to build upon four years of successful collaboration on hybrid bonding technology for advanced packaging SANTA CLARA, Calif., April 14, 2025 (GLOBE NEWSWIRE) — Applied Materials, Inc. today announced it has purchased 9 percent of the outstanding shares of the common stock of BE Semiconductor Industries N.V. (Besi), a leading manufacturer of assembly equipment for the semiconductor industry. Applied and Besi have been successfully collaborating since 2020, and recently extended their agreement, to co-develop the industry’s first fully integrated equipment solution for die-based hybrid bonding. Hybrid bonding is becoming a critical technology for advanced packaging of semiconductors as designers and manufacturers race to develop more energy-efficient chips. Hybrid bonding connects chips using...

Continue reading

Japan Gold Corp. Announces C$5 Million “Best Efforts” Private Placement (Listed Issuer Financing Exemption) Offering of Common Shares

Not for distribution to United States newswire services or for dissemination in the United States VANCOUVER, British Columbia, April 14, 2025 (GLOBE NEWSWIRE) — Japan Gold Corp. (TSXV: JG) (the “Company”) is pleased to announce that it has entered into an agreement with Canaccord Genuity Corp. and Moneta Securities (Alberta) Corp. (the “Agents”), pursuant to which the Agents have agreed to act as agents, on a “best efforts” basis, in connection with a private placement of up to 41,666,667 common shares of the Company (the “Common Shares”) at a price of C$0.12 per Common Share for gross proceeds of up to approximately C$5 million (the “Offering”). The net proceeds of the Offering will be used for exploration drilling and for general corporate purposes. The Offering is expected to close on or about May 1, 2025, or such other date...

Continue reading

Capital Southwest Announces Preliminary Estimate of Fourth Quarter 2025 Operating Results and Earnings Release and Conference Call Schedule

DALLAS, April 14, 2025 (GLOBE NEWSWIRE) — Capital Southwest Corporation (“Capital Southwest”) (Nasdaq: CSWC), an internally managed business development company focused on providing flexible financing solutions to support the acquisition and growth of middle market businesses, is pleased to announce its preliminary operating results for the fourth quarter of its 2025 fiscal year (quarter ended March 31, 2025) and its fourth quarter 2025 earnings release and conference call schedule. During the quarter ended March 31, 2025, Capital Southwest incurred $2.8 million, or $0.05 per share, of one-time net expenses related to the departure of our former President and Chief Executive Officer. Capital Southwest’s preliminary estimate of its fourth quarter 2025 pre-tax net investment income is in the range of $0.55 to $0.56 per share. The...

Continue reading

Dorman Products, Inc. Announces Date to Report First Quarter 2025 Financial Results

COLMAR, Pa., April 14, 2025 (GLOBE NEWSWIRE) — Dorman Products, Inc. (the “Company” or “Dorman”) (NASDAQ: DORM) today announced the Company will report its financial results for the first quarter ended March 29, 2025 after the closing of the Nasdaq Stock Market on May 5, 2025. The Company also announced that it is scheduled to conduct a conference call and webcast of its first quarter 2025 financial results on May 6, 2025 at 8 a.m. ET. The conference call can be accessed by dialing (888) 440-4182 within the U.S. or +1 (646) 960-0653 outside the U.S. When prompted, enter the conference ID number 1698878. A live audio webcast along with the accompanying presentation materials can be accessed on the Company’s website at Dorman Products, Inc. – Events. A replay of the webcast will be available on the Investor section of the Company’s...

Continue reading

Gray Media Promotes Mark Little to General Manager of KWQC in the Quad Cities

             ATLANTA, April 14, 2025 (GLOBE NEWSWIRE) — Gray Media announced today the promotion of Mark Little to General Manager of KWQC, the NBC affiliate in Davenport, Iowa, serving the Quad Cities market, effective May 1, 2025.   For the past three years, Mark has served as the News Director of WMC-TV in Memphis, Tennessee.             Mark has been a distinguished leader in local television stations for more than 30 years. He has led newsrooms in Missouri, South Carolina, and Mississippi.   Through his years of service, Mark has earned Station of the Year, Regional Emmy, and Murrow awards. He has partnered with a local university to establish a news presence in an underserved region of Iowa and has been recognized as one of the first news directors to introduce podcasting for local news.              Mark has served on...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.